Results
1 -
10 of
19Chantry David.
HIV entry and fusion inhibitors., Expert opinion on emerging drugs, May 2004 Vicriviroc, Entry Inhibitoren Langzeitvertr??glichkeit von CCR5-Inhibitoren, Entry Inhibitoren CCR5 antagonists: from discovery to clinical efficacy, Chemokine Biology u2014 Basic Research and Clinical Application The utility of coreceptor typing in the clinic, Entry Inhibitors in HIV Therapy Anti-HIV-1 screening of (2E)-3-(2-chloro-6-methyl/methoxyquinolin-3-yl)-1-(aryl)prop-2-en-1-ones, Medicinal Chemistry Research From in vitro EC50 to in vivo doseu2013response for antiretrovirals using an HIV disease model. Part II: Application to drug development, Journal of Pharmacokinetics and Pharmacodynamics Serious Doubts on Safety and Efficacy of CCR5 Antagonists, Infection Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5, Retrovirology